Things could hardly have gone worse for healthcare investors in 2023. While shares of Eli Lilly and Novo Nordisk rocketed amid excitement about their new.
The alert about the new variant, called JN.1, comes as hospitalizations of patients with Covid-19 are climbing in the U.S., amid a seasonal increase in.
Bluebird Bio stock plummeted after the biotech priced a stock offering at $1.50 a share. A landmark FDA approval for its sickle cell disease gene therapy has.